Report on Future Perspectives and on Opportunities and Risks

Opportunities and Risks

As a global enterprise with a diversified portfolio, the Bayer Group is exposed to a wide range of internal or external developments or events that could significantly impact the achievement of our financial and nonfinancial objectives.

Bayer regards opportunity and risk management as an integral part of corporate governance. Our risk management process and the opportunities / risks are outlined in detail in the Annual Report 2017 (Combined Management Report, Chapter “Opportunity and Risk Report”). With regard to the risks related to the acquisition of Monsanto Company, United States, we refer specifically to Chapter “Opportunities and Risks Related to the Planned Acquisition of Monsanto.”

There have been no material changes to Bayer’s overall risk profile so far compared with our commentary in the Annual Report 2017.

No risks have been identified that could endanger the Bayer Group’s continued existence. There are also no risks with mutually reinforcing dependencies that could combine to endanger the Group’s continued existence.

Significant developments that have occurred in respect of the legal risks since publication of the Bayer Annual Report 2017 (the Note “Legal Risks” to the Consolidated Financial Statements) are described in the Notes to the Condensed Consolidated Interim Financial Statements under “Legal Risks.”

Compare to Last Year